8/104 sources · 3 publishersUpdated Oct 13, 21:31 UTC
TRexBio finishes IPO after raising $116.7 million
TRex Bio completed its initial public offering on Oct. 13, 2026, selling 8,333,334 shares at $14.00 each. The company received approximately $116.7 million in gross proceeds before underwriting discounts, commissions and other offering expenses. Its shares began trading on Nasdaq's Global Select Market under TRXB.
Why it matters
The offering provides TRex Bio with new gross capital while making its shares publicly tradable. The proceeds belong to the company before offering-related deductions, so the net cash added will be lower than the gross amount.
Key facts
- 1TRex Bio sold 8,333,334 shares at $14.00 per share. investing.com
- 2The offering generated approximately $116.7 million in gross proceeds before underwriting discounts, commissions and other offering expenses. investing.com
- 3TRex Bio's registration statement became effective on October 8, 2026. stocktitan.net
- 4J.P. Morgan, Evercore ISI, Cantor and Stifel were lead book-running managers, while Wedbush PacGrow served as book-running manager. investing.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.